Progress in Cardiovascular Diseases
Volume 46, Issue 1 , Pages 11-29 , July 2003

Epidemiology of smoking-induced cardiovascular disease

  • David M Burns

      Affiliations

    • Corresponding Author InformationReprint requests: David M. Burns, MD, University of California San Diego School of Medicine, 1545 Hotel Circle South, Suite 310, San Diego, CA 92108, USA
    • University of California San Diego School of Medicine, San Diego, CA, USA

References 

  1. U.S. Department of Health, Education, and Welfare . The Health Consequences of Smoking (A Report to the Surgeon General). Washington, DC: U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration, Office on Smoking and Health; 1971; DHEW Publication No. (HSM) 71-7513
  2. U.S. Department of Health, Education, and Welfare . Smoking and Health. A Report of the Surgeon General. Washington, DC: U.S. Department of Health, Education, and Welfare, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health; 1979; DHEW Publication No. (PHS) 79-50066
  3. U.S. Department of Health and Human Services . In: The Health Consequences of Smoking (Cardiovascular Disease. A Report of the Surgeon General). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Services, Office of the Surgeon General, Office of Smoking and Health; 1983;p. 388; DHHS Publication No. (PHS) 84-50204
  4. U.S. Department of Health and Human Services . Women and Smoking (A Report of the Surgeon General). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2001;
  5. U.S. Department of Health and Human Services . The Health Consequences of Tobacco Use (A Report of the Surgeon General). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2003;
  6. Friedman GD, Dales LG, Ury HK. Mortality in middle-aged smokers and nonsmokers. N Engl J Med. 1979;300:213–217
  7. Neaton JD, Wentworth D. Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992;152:56–64
  8. Shaper AG, Pocock SJ, Walker M, et al.  Risk factors for ischaemic heart disease (The prospective phase of the British Regional Heart Study). J Epidemiol Community Health. 1985;39:197–209
  9. Criqui MH, Cowan LD, Tyroler HA, et al.  Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality (Results form the Lipid Research Clinics Follow-up Study). Am J Epidemiol. 1987;126:629–637
  10. Ragland DR, Brand RJ. Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. Am J Epidemiol. 1988;127:462–475
  11. Shaten BJ, Kuller LH, Neaton JD. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med. 1991;20:655–659
  12. Gartside PS, Wang P, Glueck CJ. Prospective assessment of coronary heart disease risk factors (The NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up). J Am Coll Nutr. 1998;17:263–269
  13. Wannamethee SG, Shaper AG, Walker M, et al.  Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middle-aged British men. Arch Intern Med. 1998;158: 2433–1440
  14. Jacobs DR, Adachi H, Mulder I, et al.  Cigarette smoking and mortality risk (Twenty-five-year follow-up of the Seven Countries Study). Arch Intern Med. 1999;159:733–740
  15. Freund KM, Belanger AJ, D’Agostino RB, et al.  The health risks of smoking. The Framingham Study (34 years of follow-up). Ann Epidemiol. 1993;3:417–424
  16. Cremer P, Nagel D, Mann H, et al.  Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis. 1997;129:221–230
  17. Blanco-Cedres L, Daviglus ML, Garside DB, et al.  Relation of cigarette smoking to 25-year mortality in middle-aged men with low baseline serum cholesterol (The Chicago Heart Association Detection Project in Industry). Am J Epidemiol. 2002;155:354–360
  18. Pooling Project Research Group . Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events (Final report of the pooling project). J Chronic Dis. 1978;31:201–306
  19. U.S. Department of Health and Human Services . The Health Benefits of Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990; DHHS Publication No. (CDC) 90-8416
  20. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis. 1976;23:451–476
  21. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis. 1983;3:187–198
  22. Auerbach O, Garfinkel L. Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest. 1980;78:805–809
  23. Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med. 1965;272:775–779
  24. Auerbach O, Hammond EC, Garfinkel L, et al.  Thickness of walls of myocardial arterioles in relation to smoking and age. Arch Environ Health. 1971;22:20–27
  25. Auerbach O, Carter HW, Garfinkel L, et al.  Cigarette smoking and coronary artery disease. A macroscopic and microscopic study. Chest. 1976;70:697–705
  26. Zieske AW, Takei H, Fallon KB, et al.  Smoking and atherosclerosis in youth. Atherosclerosis. 1999;144:403–408
  27. Rhoads GG, Blackwelder WC, Stemmermann GN, et al.  Coronary risk factors and autopsy findings in Japanese-American men. Lab Invest. 1978;38:304–311
  28. Holme I, Enger SC, Helgeland A, et al.  Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis from the Oslo study. Arteriosclerosis. 1981;1:250–256
  29. Sorlie PD, Garcia-Palmieri MR, Castillo-Staab MI, et al.  The relation of antemortem factors to atherosclerosis at autopsy. The Puerto Rico Heart Health Program. Am J Pathol. 1981;103:345–352
  30. Solberg LA, Strong JP, Holme I, et al.  Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study. Lab Invest. 1985;53:648–655
  31. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group . Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264:3018–3024
  32. McGill HC, McMahan CA, Herderick EE, et al.  Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 2000;20:836–845
  33. McGill HC, McMahan CA, Malcom GT, et al.  Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 1997;17:95–106
  34. McGill HC, McMahan CA, Zieske AW, et al.  Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation. 2001;103:1546–1550
  35. Berenson GS, Srinivasan SR, Bao W, et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650–1656
  36. Weintraub WS, Klein LW, Seelaus PA, et al.  Importance of total life consumption of cigarettes as a risk factor for coronary artery disease. Am J Cardiol. 1985;55:669–672
  37. Vander Zwaag R, Lemp GF, Hughes JP, et al.  The effect of cigarette smoking on the pattern of coronary atherosclerosis. A case-control study. Chest. 1988;94:290–295
  38. Herbert WH. Cigarette smoking and arteriographically demonstrable coronary artery disease. Chest. 1975;67:49–52
  39. Reed D, Yano K. Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program. Comparisons of cohort and arteriography series analyses. Am J Epidemiol. 1991;134:111–122
  40. Moise A, Theroux P, Taeymans Y, et al.  Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries. Am J Cardiol. 1985;56:30–34
  41. Waters D, Lesperance J, Gladstone P, et al.  Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation. 1996;94:614–621
  42. Thun M, Myers D, Day-Lally C, et al.  In:  Burns D,  Garfinkel L,  Samet JM editor. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II, in Smoking and Tobacco Control Monograph 8 Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1997;p. 383–476
  43. Rosengren A, Wilhelmsen L, Wedel H. Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med. 1992;231:357–362
  44. Doll R, Peto R. Mortality in relation to smoking (20 years’ observations on male British doctors). Br Med J. 1976;2:1525–1536
  45. Miettinen OS, Neff RK, Jick H. Cigarette-smoking and nonfatal myocardial infarction (Rate ratio in relation to age, sex and predisposing conditions). Am J Epidemiol. 1976;103:30–36
  46. Willett WC, Green A, Stampfer MJ, et al.  Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317:1303–1309
  47. Benowitz NL. In: Biomarkers of cigarette smoking. National Cancer Institute. The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes. Atlanta, GA: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1996;p. 93–111 Smoking and Tobacco Control Monograph Number 7 National Institutes of Health Publication No. 96-4028
  48. Law MR, Morris JK, Watt HC, et al.  The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer. 1997;75:1690–1693
  49. Burns DM, Shanks TG, Major JM, et al.  Smoking lower yield cigarettes and disease risks. In:  Burns DM,  Benowitz NL editor. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Atlanta, GA: U.S. Department of Health and Human Services, PHS, National Institutes of Health, National Cancer Institute; 2001; Smoking and Tobacco Control Monograph, No. 13 National Institutes of Health Pub. No. 02-5074
  50. National Cancer Institute . Risks associated with smoking cigarettes with low machine yields of tar and nicotine. Smoking and Tobacco Control Monograph No. 13 Bethesda, MD: U.S. Department of Health and Human Services, National Cancer Institute; 2001;
  51. Kuller LH. Cigarette smoking and mortality. MRFIT Research Group. Prev Med. 1991;20:638–654
  52. Tverdal A. Calculation of risk for the development of acute myocardial infarction in the normal population based on long-term follow-up studies (Smokers compared with non-smokers). J Cardiovasc Risk. 1999;6:287–291
  53. Burns D, Shanks T, Choi W, et al.  The American Cancer Society Cancer Prevention Study #1, 12-year follow-up on one million men and women. In:  Burns D,  Garfinkel L,  Samet J editor. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. Atlanta, GA: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1997;p. 113–304 Smoking and Tobacco Control, Monograph No. 8
  54. Castelli WB, Wilson PW, Levy D, et al.  Cardiovascular risk factors in the elderly. Am J Cardiol. 1989;63:12H–19H
  55. Welin L, Eriksson H, Larsson B, et al.  Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology. 1993;82:223–228
  56. Harris T, Cook EF, Kannel WB. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. J Am Geriatric Soc. 1988;36:1023–1028
  57. Benfante R, Reed D, Frank J. Does cigarette smoking have an independent effect on coronary heart disease incidence in the elderly?. Am J Public Health. 1991;81:897–899
  58. Nissinen A, Pekkanen J, Porath A, et al.  Risk factors for cardiovascular disease among 55 to 74 year-old Finnish men (A 10-year follow-up). Ann Med. 1989;21:239–240
  59. Frost PH, Davis BR, Burlando AJ, et al.  Coronary heart disease risk factors in men and women aged 60 years and older (Findings from the Systolic Hypertension in the Elderly Program). Circulation. 1996;94:26–34
  60. Houterman S, Boshuizen HC, Verschuren WM, et al.  Predicting cardiovascular risk in the elderly in different European countries. Eur Heart J. 2002;23:294–300
  61. Jajich CL, Ostfeld AM, Freeman DH. Smoking and coronary heart disease mortality in the elderly. JAMA. 1984;252:2831–2834
  62. Hermanson B, Omenn GS, Kronmal RA, et al.  Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med. 1988;319:1365–1369
  63. Kanitz MG, Giovannucci SJ, Jones JS, et al.  Myocardial infarction in young adults (Risk factors and clinical features). J Emerg Med. 1996;14:139–145
  64. Navas-Nacher EL, Colangelo L, Beam C, et al.  Risk factors for coronary heart disease in men 18 to 39 years of age. Ann Intern Med. 2001;134:433–439
  65. Gordon T, Kannel WB, McGee D, et al.  Death and coronary attacks in men after giving up cigarette smoking. Lancet. 1974;2:1345–1348
  66. Aberg A, Bergstrand R, Johansson S, et al.  Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J. 1983;49:416–422
  67. Qiao Q, Tervahauta M, Nissinen A, et al.  Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J. 2000;21:1621–1626
  68. Dagenais GR, Robitaille NM, Lupien PJ, et al.  First coronary heart disease event rates in relation to major risk factors (Quebec cardiovascular study). Can J Cardiol. 1990;6:274–280
  69. Omenn GS, Anderson KW, Kronmal RA, et al.  The temporal pattern of reduction of mortality risk after smoking cessation. Am J Prev Med. 1990;6:251–257
  70. Kawachi I, Colditz GA, Stampfer MJ, et al.  Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med. 1993;119:992–1000
  71. Kawachi I, Colditz GA, Stampfer MJ, et al.  Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med. 1994;154:169–175
  72. Daly LE, Mulcahy R, Graham IM, et al.  Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J. 1983;287:324–326
  73. Ockene JK, Kuller LH, Svendsen KH, et al.  The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health. 1990;80:954–958
  74. Vlietstra RE, Kronmal RA, Oberman A, et al.  Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA. 1986;255:1023–1027
  75. Multiple Risk Factor Intervention Trial Research Group . Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. JAMA. 1990;263:1795–1801
  76. Multiple Risk Factor Intervention Trial Research Group . Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circulation. 1996;94:946–951
  77. Rose G, Hamilton PJ, Colwell L, et al.  A randomised controlled trial of anti-smoking advice (10-year results). J Epidemiol Community Health. 1982;36:102–108
  78. Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996;93:450–456
  79. Al-Delaimy WK, Manson JE, Solomon CG, et al.  Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med. 2002;162:273–279
  80. Neaton JD, Kuller LH, Wentworth D, et al.  Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J. 1984;108:759–769
  81. Garfinkel L. Cigarette smoking and coronary heart disease in blacks (Comparison to whites in a prospective study). Am Heart J. 1984;108:802–807
  82. Keil JE, Sutherland SE, Knapp RG, et al.  Mortality rates and risk factors for coronary disease in blacks as compared with white men and women. N Engl J Med. 1993;329:73–78
  83. Keil JE, Sutherland SE, Hames CG, et al.  Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med. 1995;155:1521–1527
  84. Gillum RF. Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J. 1982;104:839–851
  85. Roig E, Castaner A, Simmons B, et al.  In-hospital mortality rates from acute myocardial infarction by race in U.S. hospitals (Findings from the National Hospital Discharge Survey). Circulation. 1987;76:280–288
  86. Taylor HA, Mickel MC, Chaitman BR, et al.  Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 1997;29:358–364
  87. Tyroler HA, Knowles MG, Wing SB, et al.  Ischemic heart disease risk factors and twenty-year mortality in middle-age Evans County black males. Am Heart J. 1984;108:738–746
  88. Rosenberg L, Palmer JR, Rao RS, et al.  Risk factors for coronary heart disease in African American women. Am J Epidemiol. 1999;150:904–909
  89. Gillum RF, Mussolino ME, Madans JH. Coronary heart disease risk factors and attributable risks in African-American women and men (NHANES I epidemiologic follow-up study). Am J Public Health. 1998;88:913–917
  90. Hames CG, Rose K, Knowles M, et al.  Black-white comparisons of 20-year coronary heart disease mortality in the Evans County Heart Study. Cardiology. 1993;82:122–136
  91. Mendelson G, Aronow WS, Ahn C. Prevalence of coronary artery disease, atherothrombotic brain infarction, and peripheral arterial disease (Associated risk factors in older Hispanics in an academic hospital-based geriatrics practice). J Am Geriatr Soc. 1998;46:481–483
  92. Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens Suppl. 1990;8:S9–S15
  93. Lam TH, He Y, Shi QL, et al.  Smoking, quitting, and mortality in a Chinese cohort of retired men. Ann Epidemiol. 2002;12:316–320
  94. Miyake Y. Fukuoka Heart Study Group. Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese. Jpn Circ J. 2000;64:103–109
  95. Sytkowski PA, D’Agostino RB, Belanger A, et al.  Sex and time trends in cardiovascular disease incidence and mortality (The Framingham Heart Study, 1950-1989). Am J Epidemiol. 1996;143:338–350
  96. Thun MJ, Day-Lally CA, Calle EE, et al.  Excess mortality among cigarette smokers (Changes in a 20-year interval). Am J Public Health. 1995;85:1223–1230
  97. Thun M, Myers D, Day-Lallym C, et al.  Trends in tobacco smoking and mortality from cigarette use in cancer prevention studies I (1959 through 1965) and II (1982 through 1988), in Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. In:  Burns D,  Garfinkel L,  Samet JM editor. Smoking and Tobacco Control Monograph 8. Bethesda, MD: U.S. DHHS, National Institutes of Health, National Cancer Institute; 1997;p. 305–382
  98. Kelly TL, Gilpin E, Ahnve S, et al.  Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J. 1985;110:535–541
  99. Molstad P. First myocardial infarction in smokers. Eur Heart J. 1991;12:753–759
  100. Barbash GI, White HD, Modan M, et al.  Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation. 1993;87:53–58
  101. Gottlieb S, Boyko V, Zahger D, et al.  Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol. 1996;28:1506–1513
  102. McElduff P, Dobson AJ. Case fatality after an acute cardiac event (The effect of smoking and alcohol consumption). J Clin Epidemiol. 2001;54:58–67
  103. Njolstad I, Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction (A prospective analysis from the Finnmark Study). Arch Intern Med. 1998;158:1326–1332
  104. Herlitz J, Karlson BW, Karlsson T, et al.  Predictors of death during 5 years after hospital discharge among patients with a suspected acute coronary syndrome with particular emphasis on whether an infarction was developed. Int J Cardiol. 1998;66:73–80
  105. Lee PN, Garfinkel L. Mortality and type of cigarette smoked. J Epidemiol Community Health. 1981;35:16–22
  106. Higenbottam T, et al.  Cigarettes, lung cancer, and coronary heart disease (The effects of inhalation and tar yield). J Epidemiol Community Health. 1982;36:113–117
  107. Tang JL, Morris JK, Wald NJ. Mortality in relation to tar yield of cigarettes (A prospective study of four cohorts). BMJ. 1995;311:1530–1533
  108. Benhamou E, Benhamou S, Flamant R. Lung cancer and women (Results of a French case-control study). Br J Cancer. 1987;55:91–95
  109. Powell JT, Edwards RJ, Worrell PC. Risk factors associated with the development of peripheral arterial disease in smokers (A case-control study). Atherosclerosis. 1997;129:41–48
  110. Parish S, Collins R, Peto R. Cigarette smoking, tar yields, and non-fatal myocardial infarction (14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators). BMJ. 1995;311:471–477
  111. Woodward M. Is compulsory restriction of tar yield of cigarettes a worthwhile public health policy?. Am J Prev Med. 2001;21:284–290
  112. Petitti DB, Friedman GD. Cardiovascular and other diseases in smokers of low yield cigarettes. J Chron Dis. 1985;38:581–588
  113. Hawthorne VM, Fry JS. Smoking and health (The association between smoking behavior, total mortality, and cardiorespiratory disease in West Central Scotland). J Epidemiol Community Health. 1978;32:260–266
  114. Palmer J, Rosenberg L, Shapiro S. Low yield cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med. 1989;320:1569–1573
  115. Negri E. Tar yield of cigarettes and risk of acute myocardial infarction. BMJ. 1993;306:1567–1569
  116. Borland C, Chamberlain A, Higenbottam T. Carbon monoxide yield of cigarettes and its relation to cardiorespiratory disease. BMJ. 1983;287:1583–1586
  117. Todd GF, Hunt BM, Lambert PM. Four cardiorespiratory symptoms as predictors of mortality. J Epidemiol Community Health. 1978;32:267–274
  118. Alderson MR, Lee PN, Wang R. Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked. J Epidemiol Community Health. 1985;39:286–293
  119. Benowitz NL, Hall SM, Herning RI, et al.  Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med. 1983;309:139–142
  120. Jarvis MJ, Boreham R, Primatesta P, et al.  Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers (Evidence from a representative population survey). J Natl Cancer Inst. 2001;93:134–138
  121. Stratton K, Shetty P, Wallace R, et al.  Clearing the smoke. Assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press; 2001;
  122. Scientific Advisory Committee on Tobacco Product Regulation (SACTob) . Recommendation on heath claims derived from ISO/FTC method to measure cigarette smoke. Geneva, Switzerland: World Health Organization; 2002;
  123. Dawber TR. In: The Framingham Study (The epidemiology of atherosclerotic Disease). Cambridge, MA: Harvard University Press; 1980;p. 267
  124. Kannel WB, Thomas HE. Sudden coronary death (The Framingham Study). Ann N Y Acad Sci. 1982;382:3–21
  125. Wannamethee G, Shaper AG, Macfarlane PW, et al.  Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995;91:1749–1756
  126. Sexton PT, Walsh J, Jamrozik K, et al.  Risk factors for sudden unexpected cardiac death in Tasmanian men. Aust N Z J Med. 1997;27:45–50
  127. Kannel WB, Doyle JT, McNamara PM, et al.  Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation. 1975;51:606–613
  128. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation. 1996;93:2033–2036
  129. Escobedo LG, Caspersen CJ. Risk factors for sudden coronary death in the United States. Epidemiology. 1997;8:175–180
  130. Kagan A, Yano K, Reed DM, et al.  Predictors of sudden cardiac death among Hawaiian-Japanese men. Am J Epidemiol. 1989;130:268–277
  131. Cupples LA, Gagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death. Circulation. 1992;85(suppl):I11–I18
  132. Peters RW, Brooks MM, Todd L, et al.  Smoking cessation and arrhythmic death (The CAST experience. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators). J Am Coll Cardiol. 1995;26:1287–1292
  133. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med. 1986;314:271–275
  134. Cosgrove DM, Loop FD, Lytle BW, et al.  Determinants of 10-year survival after primary myocardial revascularization. Ann Surg. 1985;202:480–490
  135. Myers WO, Blackstone EH, Davis K, et al.  CASS Registry long term surgical survival. Coronary Artery Surgery Study. J Am Coll Cardiol. 1999;33:488–498
  136. Kazmers A, Kohler TR. Very late survival after vascular surgery. J Surg Res. 2002;105:109–114
  137. Herlitz J, Haglid M, Albertsson P, et al.  Short- and long-term prognosis after coronary artery bypass grafting in relation to smoking habits. Cardiology. 1997;88:492–497
  138. Van Brussel BL, Plokker HW, Voors AA, et al.  Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery. Eur Heart J. 1995;16:1200–1206
  139. Cavender JB, Rogers WJ, Fisher LD, et al.  Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS) (10-year follow-up. CASS Investigators). J Am Coll Cardiol. 1992;20:287–294
  140. Arora RR, Konrad K, Badhwar K, et al.  Restenosis after transluminal coronary angioplasty (A risk factor analysis). Cathet Cardiovasc Diagn. 1990;19:17–22
  141. Violaris AG, Thury A, Regar E, et al.  Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart. 2000;84:299–306
  142. Cohen DJ, Doucet M, Cutlip DE, et al.  Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention (Another smoker’s paradox?). Circulation. 2001;104:773–778
  143. Cutlip DE, Chauhan MS, Baim DS, et al.  Clinical restenosis after coronary stenting (Perspectives from multicenter clinical trials). J Am Coll Cardiol. 2002;40:2082–2089
  144. Colditz GA, Bonita R, Stampfer MJ, et al.  Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318:937–941
  145. Wolf PA, D’Agostino RB, Kannel WB, et al.  Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988;259:1025–1029
  146. Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens. 1990;8(Suppl):S3–S8
  147. Haheim LL, Holme I, Hjermann I, et al.  Smoking habits and risk of fatal stroke (18 years follow up of the Oslo Study). J Epidemiol Community Health. 1996;50:621–624
  148. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality (A 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project). Circulation. 1998;98:1365–1371
  149. Sharrett AR, Sorlie PD, Chambless LE, et al.  Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence (The Atherosclerosis Risk in Communities Study). Am J Epidemiol. 1999;149:843–852
  150. Djousse L, Myers RH, Province MA, et al.  Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis (National Heart, Lung, and Blood Institute Family Heart Study). Stroke. 2002;33:1357–1361
  151. Hart CL, Hole DJ, Smith GD. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke. 1999;30:1999–2007
  152. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789–794
  153. Kawachi I, Colditz GA, Stampfer MJ, et al.  Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232–236
  154. Salonen R, Salonen JT. Determinants of carotid intima-media thickness (A population-based ultrasonography study in eastern Finnish men). J Intern Med. 1991;229:225–231
  155. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants (A population-based ultrasonography study). Atherosclerosis. 1990;81:33–40
  156. Howard G, Burke GL, Szklo M, et al.  Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154:1277–1282
  157. Salonen R, Tervahauta M, Salonen JT, et al.  Ultrasonographic manifestations of common carotid atherosclerosis in elderly eastern Finnish men. Prevalence and associations with cardiovascular diseases and risk factors. Arterioscler Thromb. 1994;14:1631–1640
  158. Ebrahim S, Papacosta O, Whincup P, et al.  Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women (The British Regional Heart Study). Stroke. 1999;30:841–850
  159. Ferrieres J, Elias A, Ruidavets JB, et al.  Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J Hypertens. 1999;17:743–748
  160. Fine-Edelstein JS, Wolf PA, O’Leary DH, et al.  Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology. 1994;44:1046–1050
  161. Poredos P, Orehek M, Tratnik E. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology. 1999;50:201–208
  162. Weber F. Risk factors for subclinical carotid atherosclerosis in healthy men. Neurology. 2002;59:524–528
  163. Diez-Roux AV, Nieto FJ, Comstock GW, et al.  The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med. 1995;24:48–55
  164. Crouse JR, Tang R, Espeland MA, et al.  Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation. 2002;106:2061–2066
  165. Chambless LE, Folsom AR, Davis V, et al.  Risk factors for progression of common carotid atherosclerosis (The Atherosclerosis Risk in Communities Study,1987-1998). Am J Epidemiol. 2002;155:38–47
  166. Mathiesen EB, Joakimsen O, Bonaa KH. Prevalence of and risk factors associated with carotid artery stenosis (The Tromso Study). Cerebrovasc Dis. 2001;12:44–51
  167. Csanyi A, Egervari A, Nagy Z. Influence of hypertension and smoking as the single vascular risk factors on the intima-media thickness. Eur J Epidemiol. 2001;17:855–861
  168. Liang YL, Shiel LM, Teede H, et al.  Effects of blood pressure, smoking, and their interaction on carotid artery structure and function. Hypertension. 2001;37:6–11
  169. Aminbakhsh A, Frohlich J, Mancini GB. Detection of early atherosclerosis with B mode carotid ultrasonography (Assessment of a new quantitative approach). Clin Invest Med. 1999;22:265–274
  170. Lassila HC, Tyrrell KS, Matthews KA, et al.  Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke. 1997;28:513–517
  171. Hammond EC, Horn D. Smoking and death rates (Report on forty-four months of follow-up of 187,783 men. 2. Death rates by cause). JAMA. 1958;166:1294–1308
  172. Weir JM, Dunn JE. Smoking and mortality (A prospective study). Cancer. 1970;25:105–112
  173. Strachan DP. Predictors of death from aortic aneurysm among middle-aged men (The Whitehall study). Br J Surg. 1991;78:401–404
  174. Nillson S, Carstensen JM, Pershagen G. Mortality among male and female smokers in Sweden (a 33 year follow-up). J Epidemiol Comm Health. 2001;55:825–830
  175. Kahn HA. The Dorn study of smoking and mortality among U.S. veterans (Report on 8 and one-half years of observation). In:  Haenszel W editors. Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases. Atlanta, GA: U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute; 1966;p. 1–125 National Cancer Institute Monograph No. 19
  176. Hammond EC, Garfinkel L. Coronary heart disease, stroke, and aortic aneurysm. Factors in the etiology. Arch Environ Health. 1969;19:167–182
  177. Vardulaki KA, Walker NM, Day NE, et al.  Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg. 2000;87:195–200
  178. Blanchard JF, Armenian HK, Friesen PP. Risk factors for abdominal aortic aneurysm (Results of a case-control study). Am J Epidemiol. 2000;151:575–583
  179. Alcorn HG, Wolfson SK, Sutton-Tyrrell K, et al.  Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1996;16:963–970
  180. Lee AJ, Fowkes FG, Carson MN, et al.  Smoking, atherosclerosis and risk of abdominal aortic aneurysm. Eur Heart J. 1997;18:671–676
  181. Wilmink TB, Quick CR, Day NE. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg. 1999;30:1099–1105
  182. Lederle FA, Johnson GR, Wilson SE. Abdominal aortic aneurysm in women. J Vasc Surg. 2001;34:122–126
  183. Jamrozik K, Norman PE, Spencer CA, et al.  Screening for abdominal aortic aneurysm (Lessons from a population-based study). Med J Aust. 2000;173:345–350
  184. Witteman JC, Grobbee DE, Valkenburg HA, et al.  Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in women. Circulation. 1993;88:2156–2162
  185. Lindholt JS, Heegaard NH, Vammen S, et al.  Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001;21:51–56
  186. Tornwall ME, Virtamo J, Haukka JK, et al.  Life-style factors and risk for abdominal aortic aneurysm in a cohort of Finnish male smokers. Epidemiology. 2001;12:94–100
  187. Aragon D, Clancy R, Sole ML, et al.  Variables influencing patients’ outcomes after elective aortic reconstruction surgery. Am J Crit Care. 2000;9:279–287
  188. Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg. 1999;230:289–297
  189. Weiss NS. The value of roentgenographic abdominal aortic calcification in predicting site of occlusion in arteriosclerosis obliterans. Angiology. 1972;23:136–139
  190. Kannel WB, Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics. 1973;28:61–68
  191. Wilt TJ, Davis BR, Meyers DG, et al.  Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL (Baseline results from the Cholesterol and Recurrent Events (CARE) Study). Angiology. 1996;47:533–541
  192. Price JF, Mowbray PI, Lee AJ, et al.  Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease (Edinburgh Artery Study). Eur Heart J. 1999;20:344–353
  193. Meijer WT, Grobbee DE, Hunink MG, et al.  Determinants of peripheral arterial disease in the elderly (The Rotterdam study). Arch Intern Med. 2000;160:2934–2938
  194. Ness J, Aronow WS, Ahn C. Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 2000;48:312–314
  195. Hooi JD, Stoffers HE, Kester AD, et al.  Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998;16:177–182
  196. Palumbo PJ, O’Fallon WM, Osmundson PJ, et al.  Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive?. Arch Intern Med. 1991;151:717–721
  197. Bowlin SJ, Medalie JH, Flocke SA, et al.  Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol. 1994;140:418–430
  198. Murabito JM, Evans JC, Nieto K, et al.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–965
  199. Fowkes FG, Housley E, Riemersma RA, et al.  Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135:331–340
  200. Fowler B, Jamrozik K, Norman P, et al.  Prevalence of peripheral arterial disease (Persistence of excess risk in former smokers). Aust N Z J Public Health. 2002;26:219–224
  201. Fowler B, Jamrozik K, Norman P, et al.  Improving maximum walking distance in early peripheral arterial disease (Randomised controlled trial). Aust J Physiother. 2002;48:269–275
  202. Juergens JL, Barker NW, Hines EA. Arteriosclerosis obliterans (Review of 20 cases with special reference to pathogenic and prognostic factors). Circulation. 1960;21:188–195
  203. Birkenstock WE, Louw JH, Terblanche J, et al.  Smoking and other factors affecting the conservative management of peripheral vascular disease. S Afr Med J. 1975;49:1129–1132
  204. Wray R, DePalma RG, Hubay CH. Late occlusion of aortofemoral bypass grafts (Influence of cigarette smoking). Surgery. 1971;70:969–973
  205. Myers KA, King RB, Scott DF, et al.  The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg. 1978;65:267–271
  206. Ameli FM, Stein M, Provan JL, et al.  The effect of postoperative smoking on femoropopliteal bypass grafts. Ann Vasc Surg. 1989;3:20–25
  207. Wiseman S, Kenchington G, Dain R, et al.  Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ. 1989;299:643–646
  208. National Cancer Institute . In:  Burns D,  Cummings KM,  Hoffman D editor. Cigar smoking in the United States (Health effects and trends). Atlanta, GA: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1998; Smoking and Tobacco Control Monograph No. 9
  209. Shanks T, Burns D. Disease consequences of cigar smoking. In:  Burns D,  Cummings KM,  Hoffman D editor. Cigar Smoking in the United States (Health Effects and Trends). Atlanta, GA: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1998; Smoking and Tobacco Control Monograph No. 9
  210. Jacobs EJ, Thun MJ, Apicella LF. Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch Intern Med. 1999;159:2413–2418
  211. Iribarren C, Tekawa IS, Sidney S, et al.  Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med. 1999;340:1773–1780
  212. Baker F, Ainsworth SR, Dye JT, et al.  Health risks associated with cigar smoking. JAMA. 2000;284:735–740

PII: S0033-0620(03)00079-3

doi: 10.1016/S0033-0620(03)00079-3

Progress in Cardiovascular Diseases
Volume 46, Issue 1 , Pages 11-29 , July 2003

Article Tools

* Image Usage & Resolution